Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Bio-Path Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +3 vs. Q1 2024
- Shares held
- 142.6K
- +123.6K (+648.1%) vs. Q1 2024
- Total value
- $285.1K
- +$206.5K (+262.9%) vs. Q1 2024
- New holders
- 4
- 2 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 97,000 | $194.0K | 0.01% | +97,000 | New |
| HRT Financial LP | 14,085 | $28.0K | 0.00% | +14,085 | New |
| Vanguard Group Inc | 13,502 | $27.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,866 | $21.7K | 0.00% | +10,866 | New |
| Tower Research Capital LLC (TRC) | 3,733 | $7.47K | 0.00% | +1,799+93.0% | Added |
| BlackRock Inc. | 2,381 | $4.76K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 859 | $1.72K | 0.00% | −318−27.0% | Reduced |
| Qube Research & Technologies Ltd | 100 | $200 | 0.00% | +100 | New |
| Bank of America Corp | 46 | $92 | 0.00% | +39+557.1% | Added |
| Morgan Stanley | 35 | $70 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 21 | $42 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 4 | $8 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5−100.0% | Sold out |